药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bismuth subsalicylate
Acetyldigoxin
Regorafenib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
Bismuth subsalicylate
Metildigoxin
Regorafenib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
Bismuth subsalicylate
Erdafitinib
The serum concentration of Erdafitinib can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Thyrotropin
The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Benzylthiouracil
The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Elcatonin
The therapeutic efficacy of Elcatonin can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Methylthiouracil
The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
3,5-diiodothyropropionic acid
The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Protirelin
The therapeutic efficacy of Protirelin can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Potassium perchlorate
The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Thyroid, porcine
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Dibromotyrosine
The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Potassium Iodide
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Teriparatide
The therapeutic efficacy of Teriparatide can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Parathyroid hormone
The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Abaloparatide
The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Tiratricol
The therapeutic efficacy of Tiratricol can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
3,5-Diiodotyrosine
The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Regorafenib.
Bismuth subsalicylate
Emapalumab
The metabolism of Regorafenib can be increased when combined with Emapalumab.
Bismuth subsalicylate
Secukinumab
The metabolism of Regorafenib can be increased when combined with Secukinumab.